Curated News: Journal of Experimental Medicine

Filters close
25-Jun-2020 12:05 PM EDT
New Strategy Emerges for Vaccine Against Methicillin-Resistant Staphylococcal Aureus
NYU Langone Health

Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments.

Newswise: Early clinical trial supports tumor cell–based vaccine for mantle cell lymphoma
16-Jun-2020 9:00 AM EDT
Early clinical trial supports tumor cell–based vaccine for mantle cell lymphoma
The Rockefeller University Press

A phase I/II clinical trial by researchers at Stanford University suggests that vaccines prepared from a patient’s own tumor cells may prevent the incurable blood cancer mantle cell lymphoma (MCL) from returning after treatment. The study, which will be published June 19 in the Journal of Experimental Medicine (JEM), reveals that the vaccines are a safe and effective way to induce the body’s immune system to attack any tumor cells that could cause disease relapse.

Newswise: Preventing pancreatic cancer metastasis by keeping cells “sheltered in place”
5-Jun-2020 1:05 PM EDT
Preventing pancreatic cancer metastasis by keeping cells “sheltered in place”
Sanford Burnham Prebys Medical Discovery Institute

Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that pancreatic cancer metastasis—when tumor cells gain the deadly ability to migrate to new parts of the body—can be suppressed by inhibiting a protein called Slug that regulates cell movement. The study, published in the Journal of Experimental Medicine, also revealed two druggable targets that interact with Slug and hold promise as treatments that may stop the spread of pancreatic cancer.

Newswise: Fighting Mosquito-Borne Viruses Requires a Precise Balance of Immune Cells
4-Jun-2020 2:35 PM EDT
Fighting Mosquito-Borne Viruses Requires a Precise Balance of Immune Cells
La Jolla Institute for Immunology

In a new study, published June 5, 2020, in the Journal of Experimental Medicine, scientists at La Jolla Institute for Immunology (LJI) shows that antibodies against JEV are “cross-reactive” and can also recognize Zika virus. Unfortunately, these antibodies can actually make Zika cases more severe.

Newswise: Continued nicotine use promotes brain tumors in lung cancer patients, Wake Forest study suggests
1-Jun-2020 9:00 AM EDT
Continued nicotine use promotes brain tumors in lung cancer patients, Wake Forest study suggests
The Rockefeller University Press

Researchers at Wake Forest School of Medicine have discovered that nicotine promotes the spread of lung cancer cells into the brain, where they can form deadly metastatic tumors. The study, which will be published June 4 in the Journal of Experimental Medicine (JEM), suggests that nicotine replacement therapies may not be suitable strategies for lung cancer patients attempting to quit smoking. In addition, the researchers show that the naturally occurring drug parthenolide blocks nicotine-induced brain metastasis in mice, suggesting a potential therapeutic option in humans.

3-Jun-2020 1:35 PM EDT
Scientists Discover that Nicotine Promotes Spread of Lung Cancer to the Brain
Wake Forest Baptist Health

Among people who have the most common type of lung cancer, up to 40% develop metastatic brain tumors, with an average survival time of less than six months.

Newswise: Swelling of Tissues Drives Immune System Activity, UCLA Researchers Find
Released: 2-Jun-2020 1:30 PM EDT
Swelling of Tissues Drives Immune System Activity, UCLA Researchers Find
University of California, Los Angeles (UCLA), Health Sciences

A UCLA research team has identified a new paradigm for understanding the regulation of the immune system, potentially paving the way for new approaches to treating infections and immune-related diseases such as type 1 diabetes and certain cancers.

Newswise: Researchers identify therapeutic targets to prevent cancer-associated muscle loss
19-May-2020 11:15 AM EDT
Researchers identify therapeutic targets to prevent cancer-associated muscle loss
The Rockefeller University Press

Researchers at the University of Nebraska Medical Center have identified a key cell signaling pathway that drives the devastating muscle loss, or cachexia, suffered by many cancer patients. The study, which will be published May 22 in the Journal of Experimental Medicine, suggests that targeting this pathway with a drug already in phase 2 clinical trials for diabetes could prevent this syndrome.

Newswise: Could cancer immunotherapy success depend on gut bacteria?
Released: 6-Mar-2020 3:40 PM EST
Could cancer immunotherapy success depend on gut bacteria?
UT Southwestern Medical Center

Gut bacteria can penetrate tumor cells and boost the effectiveness of an experimental immunotherapy that targets the CD47 protein.

Newswise: Gut bacteria can penetrate tumors and aid cancer therapy, study suggests
2-Mar-2020 8:45 AM EST
Gut bacteria can penetrate tumors and aid cancer therapy, study suggests
The Rockefeller University Press

Researchers at the University of Texas Southwestern Medical Center and University of Chicago have discovered that bacteria that usually live in the gut can accumulate in tumors and improve the effectiveness of immunotherapy in mice. The study, which will be published March 6 in the Journal of Experimental Medicine (JEM), suggests that treating cancer patients with Bifidobacteria might boost their response to CD47 immunotherapy, a wide-ranging anti-cancer treatment that is currently being evaluated in several clinical trials.

Newswise: Activating Immune Cells Could Revitalize the Aging Brain, Study Suggests
29-Jan-2020 8:05 AM EST
Activating Immune Cells Could Revitalize the Aging Brain, Study Suggests
The Rockefeller University Press

Researchers at Albany Medical College in New York have discovered that a specific type of immune cell accumulates in older brains, and that activating these cells improves the memory of aged mice. The study, which will be published February 5 in the Journal of Experimental Medicine (JEM), suggests that targeting these cells might reduce age-related cognitive decline and combat aging-associated neurodegenerative disease in humans.

Newswise: Breaking the dogma: Key cell death regulator has more than one way to get the job done
Released: 23-Dec-2019 1:55 PM EST
Breaking the dogma: Key cell death regulator has more than one way to get the job done
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital have discovered a new way that the molecule RIPK1 leads to cell death in infected, damaged or unwanted cells showing that more than one mechanism can trigger the process. The findings appeared online today in the Journal of Experimental Medicine.

Newswise: Scientists Find Molecular Key to Body Making Healthy T Cells
24-Oct-2019 11:05 AM EDT
Scientists Find Molecular Key to Body Making Healthy T Cells
Cincinnati Children's Hospital Medical Center

In a finding that could help lead to new therapies for immune diseases like multiple sclerosis and IBD, scientists report in the Journal of Experimental Medicine identifying a gene and family of proteins critical to the formation of mature and fully functioning T cells in the immune system.

Newswise: Creatine powers T cells’ fight against cancer
Released: 18-Oct-2019 12:05 PM EDT
Creatine powers T cells’ fight against cancer
UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

The study, conducted in mice, is the first to show that creatine uptake is critical to the anti-tumor activities of killer T cells, the foot soldiers of the immune system.

Newswise: Researchers Identify New Therapeutic Target for Pulmonary Fibrosis
7-Oct-2019 9:00 AM EDT
Researchers Identify New Therapeutic Target for Pulmonary Fibrosis
The Rockefeller University Press

Researchers in Japan have identified a genetic mutation that causes a severe lung disease called idiopathic pulmonary fibrosis (IPF) by killing the cells lining the lung’s airways. The study, which will be published October 10 in the Journal of Experimental Medicine (JEM), suggests that protecting these cells by inhibiting a cell death pathway called necroptosis could be a new therapeutic approach to treating IPF.

Newswise:Video Embedded targeting-immune-cells-may-be-potential-therapy-for-alzheimer-s
VIDEO
7-Oct-2019 5:05 PM EDT
Targeting immune cells may be potential therapy for Alzheimer’s
Washington University in St. Louis

A study from Washington University School of Medicine in St. Louis has found that microglia drive neurodegeneration in diseases, including Alzheimer's disease, that are linked to tau protein. Targeting microglia may help treat such diseases.

Newswise: Birth defects associated with Zika virus infection may depend on mother’s immune response, study suggests
7-Aug-2019 8:05 AM EDT
Birth defects associated with Zika virus infection may depend on mother’s immune response, study suggests
The Rockefeller University Press

New research led by scientists at The Rockefeller University in New York may help explain why Zika virus infection causes birth defects in some children but not others. The study, which will be published August 14 in the Journal of Experimental Medicine, suggests that the risk of developing an abnormally small head (microcephaly) depends on the types of antibody produced by pregnant mothers in response to Zika infection.

Newswise: Precision Editing of Gut Bacteria Reduces Cancer in Mice
Released: 31-Jul-2019 5:00 PM EDT
Precision Editing of Gut Bacteria Reduces Cancer in Mice
UT Southwestern Medical Center

UT Southwestern researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice.

Newswise: To kill tumors, activate this elite group of T cells
Released: 21-Jun-2019 5:05 PM EDT
To kill tumors, activate this elite group of T cells
La Jolla Institute for Immunology

Tissue-resident memory T cells (TRMs) are known to help the body fight infection, but they are also key tumor fighters. A new study reveals that these cells are unique in their ability to seek out and kill tumor cells without suffering from the common phenomenon of T cell “exhaustion.”

Newswise: Researchers find genetic cause for fatal response to Hepatitis A
12-Jun-2019 9:00 AM EDT
Researchers find genetic cause for fatal response to Hepatitis A
The Rockefeller University Press

Researchers have identified a genetic mutation that caused an 11-year-old girl to suffer a fatal reaction to infection with the Hepatitis A virus (HAV). The study, which will be published June 18 in the Journal of Experimental Medicine, reveals that mutations in the IL18BP gene causes the body’s immune system to attack and kill healthy liver cells, and suggests that targeting this pathway could prevent the deaths of patients suffering rapid liver failure in response to viral infection.

Newswise: Researchers identify human protein that aids development of malaria parasite
5-Jun-2019 10:05 AM EDT
Researchers identify human protein that aids development of malaria parasite
The Rockefeller University Press

Researchers in Japan have discovered that the Plasmodium parasites responsible for malaria rely on a human liver cell protein for their development into a form capable of infecting red blood cells and causing disease. The study, which will be published June 12 in the Journal of Experimental Medicine, suggests that targeting this human protein, known as CXCR4, could be a way to block the parasite’s life cycle and prevent the development of malaria.

Newswise: Researchers identify new roles for common oncogene MYC
22-May-2019 9:25 AM EDT
Researchers identify new roles for common oncogene MYC
The Rockefeller University Press

Cancer researchers have discovered surprising new functions for a protein called MYC, a powerful oncogene that is estimated to drive the development of almost half a million new cancer cases in the US every year. The study, which will be published May 29 in the Journal of Experimental Medicine, shows that MYC affects the efficiency and quality of protein production in lymphoma cells, fueling their rapid growth and altering their susceptibility to immunotherapy.

Newswise: Antibiotic treatment alleviates Alzheimer’s disease symptoms in male mice, study reveals
13-May-2019 9:00 AM EDT
Antibiotic treatment alleviates Alzheimer’s disease symptoms in male mice, study reveals
The Rockefeller University Press

Researchers at The University of Chicago have demonstrated that the type of bacteria living in the gut can influence the development of Alzheimer’s disease symptoms in mice. The study, which will be published May 16 in the Journal of Experimental Medicine, shows that, by altering the gut microbiome, long-term antibiotic treatment reduces inflammation and slows the growth of amyloid plaques in the brains of male mice, though the same treatment has no effect on female animals.

Released: 6-May-2019 1:05 PM EDT
Obesity reprograms immune cells in breasts to promote tumor formation
University of Chicago Medical Center

Macrophages in adipose tissue (fat) link obesity to triple-negative breast cancer. Instead of fighting breast cancer, these immune cells actually promote it.

Newswise: Researchers identify early indicators of pregnancy complications in lupus patients
4-Apr-2019 10:05 AM EDT
Researchers identify early indicators of pregnancy complications in lupus patients
The Rockefeller University Press

A study of pregnant women with systemic lupus erythematosus has identified early changes in the RNA molecules present in the blood that could be used to determine the likelihood of them developing preeclampsia. The study, which will be published April 8 in the Journal of Experimental Medicine, may also help researchers develop treatments to prevent other pregnancy complications associated with lupus, including miscarriage and premature birth.

Newswise: Researchers discover why men are more likely to develop liver cancer
27-Mar-2019 11:05 AM EDT
Researchers discover why men are more likely to develop liver cancer
The Rockefeller University Press

Researchers in Spain have discovered that a hormone secreted by fat cells that is present at higher levels in women can stop liver cells from becoming cancerous. The study, which will be published April 3 in the ournal of Experimental Medicine, helps explain why hepatocellular carcinoma (HCC) is more common in men, and could lead to new treatments for the disease, which is the fourth leading cause of cancer-related death worldwide.

Newswise:Video Embedded researchers-discover-how-tumor-killing-immune-cells-attack-lymphomas-in-living-mice
VIDEO
25-Mar-2019 9:00 AM EDT
Researchers Discover How Tumor-Killing Immune Cells Attack Lymphomas in Living Mice
The Rockefeller University Press

In a study that will be published April 1 in the Journal of Experimental Medicine, researchers from the Institut Pasteur and INSERM reveal that chimeric antigen receptor (CAR) T cells can induce tumor regression by directly targeting and killing cancer cells, uncovering new details of how these immune cells work and how their effectiveness could be improved in the treatment of non-Hodgkin’s lymphoma and other B cell cancers.

Newswise: Epigenetic protein could be new therapeutic target in acute myeloid leukemia, study suggests
14-Mar-2019 8:05 AM EDT
Epigenetic protein could be new therapeutic target in acute myeloid leukemia, study suggests
The Rockefeller University Press

British researchers have discovered that an epigenetic protein called EZH2 delays the development of acute myeloid leukemia (AML) but then switches sides once the disease is established to help maintain tumor growth. The study, which will be published March 19 in the Journal of Experimental Medicine, suggests that targeting EZH2 could therefore be an effective treatment for AML, an aggressive blood cancer expected to kill over 10,000 people in the US alone this year.

Newswise: German Researchers Discover How Sleep Can Fight an Infection
6-Feb-2019 9:00 AM EST
German Researchers Discover How Sleep Can Fight an Infection
The Rockefeller University Press

Researchers in Germany have discovered why sleep can sometimes be the best medicine. Sleep improves the potential ability of some of the body’s immune cells to attach to their targets, according to a new study that will be published February 12 in the Journal of Experimental Medicine. The study, led by Stoyan Dimitrov and Luciana Besedovsky at the University of Tübingen, helps explain how sleep can fight off an infection, whereas other conditions, such as chronic stress, can make the body more susceptible to illness.

Newswise: Researchers develop human cell-based model to study small cell lung cancer
4-Feb-2019 9:35 AM EST
Researchers develop human cell-based model to study small cell lung cancer
The Rockefeller University Press

Researchers from Weill Cornell Medicine have used human embryonic stem cells to create a new model system that allows them to study the initiation and progression of small cell lung cancer (SCLC). The study, which will be published February 8 in the Journal of Experimental Medicine, reveals the distinct roles played by two critical tumor suppressor genes that are commonly mutated in these highly lethal cancers.

Newswise: Study Suggests Aspirin May Help Some Patients Survive Head and Neck Cancer
22-Jan-2019 9:50 AM EST
Study Suggests Aspirin May Help Some Patients Survive Head and Neck Cancer
The Rockefeller University Press

Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may help some patients with head and neck cancer survive the disease, according to a study led by Professor Jennifer Grandis at the University of California, San Francisco. The study, which will be published January 25 in the Journal of Experimental Medicine, indicates that NSAIDs are effective in patients with mutations in a gene called PIK3CA, likely by lowering the levels of an inflammatory molecule called prostaglandin E2.

Newswise: Anti-flu antibodies can inhibit two different viral proteins, NIH study reveals
22-Jan-2019 2:05 PM EST
Anti-flu antibodies can inhibit two different viral proteins, NIH study reveals
The Rockefeller University Press

Researchers from the National Institutes of Health have discovered that antibodies that may form the basis of a universal flu vaccine inhibit a second viral protein in addition to the one that they bind. The study, to be published January 25 in the Journal of Experimental Medicine, reveals that antibodies that recognize the viral surface protein hemagglutinin can also inhibit the viral neuraminidase, and that this enhances antibody neutralization of the virus and the activation of innate immune cells with anti-viral activity.

Newswise: Gene therapy blocks peripheral nerve damage in mice
Released: 17-Jan-2019 12:05 PM EST
Gene therapy blocks peripheral nerve damage in mice
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have developed a gene therapy that blocks axonal degeneration, preventing axon destruction in mice and suggesting a therapeutic strategy that could help prevent the loss of peripheral nerves in multiple conditions.

Newswise: Stroke drug may also prevent Alzheimer’s disease, say USC researchers
8-Jan-2019 9:45 AM EST
Stroke drug may also prevent Alzheimer’s disease, say USC researchers
The Rockefeller University Press

Researchers from the University of Southern California have discovered that a drug currently being developed to treat stroke patients could also prevent Alzheimer’s disease. The study, which will be published January 15 in the Journal of Experimental Medicine, shows that the genetically engineered protein 3K3A-APC protects the brains of mice with Alzheimer’s-like symptoms, reducing the buildup of toxic peptides and preventing memory loss.

Newswise: DNA “Webs” Aid Ovarian Cancer Metastasis, Study Reveals
12-Dec-2018 10:05 AM EST
DNA “Webs” Aid Ovarian Cancer Metastasis, Study Reveals
The Rockefeller University Press

Researchers from the University of Texas MD Anderson Cancer Center have discovered that ovarian cancer cells spread, or metastasize, to new tissue after being caught in DNA "webs" extruded by immune cells. The study, which will be published December 19 in the Journal of Experimental Medicine, reveals that preventing immune cells from forming these webs reduces metastasis in mice, suggesting that similar treatments could be used to limit the spread of ovarian cancer in humans.

Newswise: Tuberculosis survives by using host system against itself
Released: 5-Dec-2018 12:05 PM EST
Tuberculosis survives by using host system against itself
University of Notre Dame

In a new study published in the Journal of Experimental Medicine, scientists at the University of Notre Dame have discovered that the pathogen Mycobacterium tuberculosis (MTB) releases RNA into infected cells.

Newswise: Breast Cancers Enhance Their Growth by Recruiting Cells From Bone Marrow
15-Nov-2018 10:05 AM EST
Breast Cancers Enhance Their Growth by Recruiting Cells From Bone Marrow
The Rockefeller University Press

Researchers in Israel have discovered that breast tumors can boost their growth by recruiting stromal cells originally formed in the bone marrow. The study, which will be published November 23 in the Journal of Experimental Medicine, reveals that the recruitment of bone marrow–derived fibroblasts lowers the odds of surviving breast cancer, but suggests that targeting these cells could be an effective way of treating the disease.

Newswise: Researchers Describe Novel Immune Syndrome
15-Oct-2018 9:45 AM EDT
Researchers Describe Novel Immune Syndrome
The Rockefeller University Press

Researchers from Australia and Japan have discovered a new human immunodeficiency syndrome in two patients on separate continents. The study, which will be published October 18 in the Journal of Experimental Medicine, reveals that a mutation in a gene called IKBKB disrupts the immune system, leading to excessive inflammation and the loss of both T and B white blood cells.

Newswise: T Cells in the Urine of Bladder Cancer Patients Reflect Tumor Environment
Released: 26-Sep-2018 12:05 PM EDT
T Cells in the Urine of Bladder Cancer Patients Reflect Tumor Environment
The Rockefeller University Press

Scientists in the UK have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumor environment, according to the study “Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment,” by Wong et al., published today in the Journal of Experimental Medicine.

Newswise: Hypertension Drugs Could Prevent Memory Loss in Lupus Patients, Study Suggests
4-Sep-2018 8:05 AM EDT
Hypertension Drugs Could Prevent Memory Loss in Lupus Patients, Study Suggests
The Rockefeller University Press

Researchers from The Feinstein Institute for Medical Research have discovered that the activation of brain cells called microglia likely contributes to the memory loss and other cognitive impairments suffered by many patients with systemic lupus erythematosus (SLE). The study, which will be published September 5 in the Journal of Experimental Medicine, shows that ACE inhibitors—a class of drugs commonly used to treat hypertension—can block this process in mice and might therefore be used to preserve the memory of lupus patients.

Newswise: Researchers Identify New Potential Biotherapy for Alzheimer’s Disease
22-Aug-2018 9:50 AM EDT
Researchers Identify New Potential Biotherapy for Alzheimer’s Disease
The Rockefeller University Press

Researchers at the University of Florida have discovered that a modified version of an important immune cell protein could be used to treat Alzheimer’s disease. The study, which will be published August 29 in the Journal of Experimental Medicine, reveals that soluble versions of a protein called TLR5 can reduce the buildup of amyloid plaques in the brains of Alzheimer’s disease model mice and prevent the toxic peptide that forms these plaques from killing neurons.

Newswise: Researchers Reveal Miscarriage Cause, Key Cellular Targets of Potential Drugs
15-Aug-2018 1:05 PM EDT
Researchers Reveal Miscarriage Cause, Key Cellular Targets of Potential Drugs
University of North Carolina Health Care System

Researchers discovered a gene mutation underlying hydrops fetalis – a fatal condition to fetuses. The proteins at the center of this finding are implicated in a number of diseases, opening avenues of potential drug discovery related to migraines, diabetes, osteoporosis, and other conditions.

Newswise: Host Antibodies Shape Gut Microbiome by Changing Bacteria Gene Expression
17-Jul-2018 10:50 AM EDT
Host Antibodies Shape Gut Microbiome by Changing Bacteria Gene Expression
The Rockefeller University Press

Researchers at the RIKEN Center for Integrative Medical Science in Japan have discovered how antibodies secreted in the gut promote the growth of beneficial bacteria. Their study, which will be published July 24 in the Journal of Experimental Medicine, shows that immunoglobulin A (IgA) antibodies can alter the expression of bacterial genes, allowing different bacterial species to cooperate with each other and form a community that can protect the body from disease.

Newswise: Immune Cells That Create and Sustain Chronic Inflammatory Bowel Disease Identified
Released: 26-Jun-2018 2:05 PM EDT
Immune Cells That Create and Sustain Chronic Inflammatory Bowel Disease Identified
University of Alabama at Birmingham

In preclinical experiments, Laurie Harrington and colleagues have discovered a subset of immune cells that create and sustain chronic inflammatory bowel disease. These cells could become potential therapeutic targets to ameliorate or cure Crohn’s disease and ulcerative colitis.

Newswise: Researchers Identify Brain Cells Responsible for Removing Damaged Neurons After Injury
19-Jun-2018 9:00 AM EDT
Researchers Identify Brain Cells Responsible for Removing Damaged Neurons After Injury
The Rockefeller University Press

Researchers at the University of Virginia School of Medicine have discovered that microglia, specialized immune cells in the brain, play a key role in clearing dead material after brain injury. The study, which will be published June 25 in the Journal of Experimental Medicine, reveals that microglia gobble up the remnants of injured neurons, which could prevent the damage from spreading to neighboring neurons and causing more extensive neurodegeneration.

Newswise: Single Surface Protein Boosts Multiple Oncogenic Pathways in Acute Myeloid Leukemia, Study Reveals
14-May-2018 10:05 AM EDT
Single Surface Protein Boosts Multiple Oncogenic Pathways in Acute Myeloid Leukemia, Study Reveals
The Rockefeller University Press

Researchers from the Albert Einstein College of Medicine in New York have discovered that a signaling protein elevated in patients with acute myeloid leukemia (AML) plays a much wider role in the disease than previously thought. The study, which will be published May 17 in the Journal of Experimental Medicine, raises hopes that current efforts to target this signaling protein could be a successful strategy to treat AML and other blood cancers.

Newswise: Cell Type Switch Helps Colon Cancer Evade Treatment, Study Suggests
9-May-2018 9:05 AM EDT
Cell Type Switch Helps Colon Cancer Evade Treatment, Study Suggests
The Rockefeller University Press

Researchers in Germany have discovered that colon cancers are often resistant to existing drug treatments because they are composed of two different cell types that can replace each other when one cell type is killed. The study, which will be published May 16 in the Journal of Experimental Medicine, suggests that combination therapies targeting both cell types at once may be more effective at treating colorectal cancer, the third highest cause of cancer-related death in the United States.

Newswise: Osteoporosis Drug Could Be Used to Treat Aggressive Form of Breast Cancer, Researchers Say
30-Apr-2018 9:40 AM EDT
Osteoporosis Drug Could Be Used to Treat Aggressive Form of Breast Cancer, Researchers Say
The Rockefeller University Press

Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer, an aggressive form of the disease that is largely untreatable. But the study, which will be published May 4 in the Journal of Experimental Medicine, reveals that the widely used osteoporosis drug zoledronic acid inhibits UGT8 and prevents the spread of basal-like breast cancer in mice, suggesting that this drug could also be used to treat the disease in humans.

Newswise: Multiple Sclerosis Drug Could Reduce Painful Side Effects of Common Cancer Treatment, Researchers Suggest
23-Apr-2018 9:05 AM EDT
Multiple Sclerosis Drug Could Reduce Painful Side Effects of Common Cancer Treatment, Researchers Suggest
The Rockefeller University Press

Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, which will be published April 27 in the Journal of Experimental Medicine, suggests that a drug already approved to treat multiple sclerosis could mitigate this effect, allowing myeloma patients to successfully complete their treatment and relieving the pain of myeloma survivors.

Newswise: Researchers Identify New Drugs That Could Help Prevent Hearing Loss
28-Feb-2018 10:05 AM EST
Researchers Identify New Drugs That Could Help Prevent Hearing Loss
The Rockefeller University Press

Researchers from St. Jude Children’s Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study, which will be published March 7 in the Journal of Experimental Medicine, suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.


Showing results

150 of 110

close
1.0834